Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

Shipley, William U., Seiferheld, Wendy, Lukka, Himanshu R., Major, Pierre P., Heney, Niall M., Grignon, David J., Sartor, Oliver, Patel, Maltibehn P., Bahary, Jean-Paul, Zietman, Anthony L., Pisansky, Thomas M., Zeitzer, Kenneth L., Lawton, Colleen A.F., Feng, Felix Y., Lovett, Richard D., Balogh, Alexander G., Souhami, Luis, Rosenthal, Seth A., Kerlin, Kevin J., Dignam, James J., Pugh, Stephanie L., Sandler, Howard M.·2017·New England Journal of Medicine
DOI 10.1056/nejmoa1607529

Cited by (665)

Items 301–400 of 665

  1. Case series on multiple prostate re-irradiation for locally recurrent prostate cancer: something ventured, something gained
    Stefania Volpe, Barbara Alicja Jereczek‐Fossa, Dario Zerini, Damaris Patricia Rojas, Cristiana Iuliana Fodor, Andrea Vavassori, Paola Romanelli, S. Vigorito, E. Rondi, Stefania Comi et al. · 2018 · Neoplasma
  2. Type of patients in whom biochemical recurrence after radical prostatectomy can be observed without salvage therapy
    Kazuhiro Matsumoto, Naoya Niwa, Masayuki Hagiwara, Takeo Kosaka, Nobuyuki Tanaka, Toshikazu Takeda, Shinya Morita, Ryuichi Mizuno, Toshiaki Shinojima, Satoshi Hara et al. · 2019 · World Journal of Urology
  3. 18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up
    Rolando Maria D’Angelillo, Michele Fiore, Luca Eolo Trodella, Rosa Sciuto, Edy Ippolito, Alessia Carnevale, Aurelia Iurato, Marianna Miele, Pasquale Trecca, Lucio Trodella et al. · 2020 · La radiologia medica
  4. PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome – 5 year follow-up of a prospective observational study
    Adalsteinn Gunnlaugsson, Elisabeth Kjellén, Ola Bratt A, Göran Ahlgren, Vilberg Jóhannesson, René Blom, Per Gunnar Nilsson · 2020 · Clinical and Translational Radiation Oncology
  5. Diagnostic performance of F-18 fluciclovine PET/CT in post-radical prostatectomy prostate cancer patients with rising prostate-specific antigen level ≤0.5 ng/mL
    Ajalaya Teyateeti, Bilal Khan, Achiraya Teyateeti, Bo Chen, Jidapa Bridhikitti, Tinsu Pan, Wei Jun Peng, Homer A. Macapinlac, Yang Lü · 2020 · Nuclear Medicine Communications
  6. Outcomes and Prediction Models for Exclusive Prostate Bed Salvage Radiotherapy among Patients with Biochemical Recurrence after Radical Prostatectomy
    Chi‐Shin Tseng, Yu-Jen Wang, Chung‐Hsin Chen, Shuo‐Meng Wang, Kuo‐How Huang, Po‐Ming Chow, Yeong‐Shiau Pu, Chao‐Yuan Huang, Jason Chia‐Hsien Cheng · 2021 · Cancers
  7. Prognostic factors in post-prostatectomy salvage radiotherapy setting with and without hormonotherapy: An individual patient data analysis of randomized trials from ICECaP database
    Pascal Pommier, Wanling Xie, Praful Kumar Ravi, C. Carrié, James J. Dignam, Felix Yi-Chung Feng, Paul Sargos, Silke Gillessen, Daniel Eidelberg Spratt, Bertrand F. TOMBAL et al. · 2024 · Radiotherapy and Oncology
  8. Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma
    Ilham Badrane, Angelo Castello, Matteo Brunelli, Corrado Cittanti, Sara Adamantiadis, Ilaria Bagni, Noemi Mindicini, Federica Lancia, Massimo Castellani, Licia Uccelli et al. · 2024 · Biomolecules
  9. Combining MRI radiomics, hypoxia gene signature score and clinical variables for prediction of biochemical recurrence-free survival after radiotherapy in prostate cancer
    Jim Zhong, Angela Davey, Russell Thomas Frood, Alan McWilliam, Jane Shortall, Mark Reardon, Kimberley Reaves, Martin Swinton, Oliver Hulson, Catharine West et al. · 2025 · La radiologia medica
  10. Prostate tissue ablation and drug delivery by an image-guided injectable ionic liquid in ex vivo and in vivo models
    Yusuf Mert Demirlenk, Hassan Albadawi, Zefu Zhang, Dila Atar, Enes Çevik, Hyeongseop Keum, Jinjoo Kim, Suliman Rehman, Seyda Gulenay Gunduz, Erin H. Graf et al. · 2024 · Science Translational Medicine
  11. The inflammation-related biomarker CXCR7 independently predicts patient outcome after radical prostatectomy
    Pedro Bargão Santos, João Lobo, Ana Félix, FERNANDA ATILA BARBOSA NUNES DA SILVA, Rita Theias Manso, João Costa, Beatriz Lourenço, José Pedro Sequeira, Cármen Jerónimo, HITENDRA R.H. PATEL et al. · 2020 · Urologic Oncology Seminars and Original Investigations
  12. A novel 8-gene panel for prediction of early biochemical recurrence in patients with prostate cancer after radical prostatectomy.
    Jinan Guo, Chenhui Zhao, Xinzhou Zhang, Zhong Wan, Tingting Chen, Jiashun Miao, Jinping Cai, Wenchuan Xie, Hao Chen, Mengli Huang et al. · 2022 · PubMed Central
  13. Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database
    Asuncion Hervas, Antonio Gómez‐Caamaño, M. Casaña, Alfonso Gomez Iturriaga, Jorge Pastor, Josep Jové, José Luis Mengual, Carmen González San Segundo, J. Muñoz · 2017 · Clinical & Translational Oncology
  14. Post-prostatectomy radiation therapy for locally recurrent prostate cancer
    Sudhir Isharwal, Andrew J. Stephenson · 2017 · Expert Review of Anticancer Therapy
  15. First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy
    Richard Kenneth Valicenti, Stephanie L. Pugh, Edouard John Trabulsi, Oliver A. Sartor, Eric C. Ko, Michael R. Girvigian, Seth A. Rosenthal, Mark E. Shaves, Jeannie Hoffman-Censits, John M. Schallenkamp et al. · 2017 · International Journal of Radiation Oncology*Biology*Physics
  16. Contemporary role of postoperative radiotherapy for prostate cancer
    Alan Dal Pra, Matthew C. Abramowitz, Radka S. Stoyanova, Alan S Pollack · 2018 · Translational Andrology and Urology
  17. Consensus statements on the management of clinically localized prostate cancer from the Hong Kong Urological Association and the Hong Kong Society of Uro‐Oncology
    Wai‐Kit Ma, Darren M.C. Poon, Chi-Kwok Chan, Tim‐Wai Chan, Foon‐Yiu Cheung, Lap‐Yin Ho, Eric Ka‐Chai Lee, Angus Kwong‐Chuen Leung, Simon Yiu‐Lam Leung, Hing‐Shing So et al. · 2019 · British Journal of Urology
  18. A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)
    Roche Kapoor, Matthew Pierre Deek, Riley McIntyre, Natasha Raman, Megan N. Kummerlowe, Iyah Chen, M. Gaver, Hao Wang, Sam R. Denmeade, Tamara Levin Lotan et al. · 2019 · BMC Cancer
  19. Current and emerging therapies for localized high-risk prostate cancer
    Lisa Moris, Gaëtan Devos, Thomas Van den Broeck, Daimantas Milonas, Maarten Albersen, Charlien Berghen, Gert De Meerleer, Wout Devlies, Wouter Everaerts, Thomas Gevaert et al. · 2020 · Expert Review of Anticancer Therapy
  20. Patterns of care for prostate cancer radiotherapy—results from a survey among German-speaking radiation oncologists
    Marco M. E. Vogel, Sabrina Dewes, Eva Katharina Sage, Michal Devečka, Jürgen E. Gschwend, Kilian Schiller, Stephanie Elisabeth Combs · 2021 · Strahlentherapie und Onkologie
  21. Postoperative radiotherapy after upfront radical prostatectomy: debated issues at a turning point—a survey exploring management trends on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology)
    Giulio Francolini, Giorgia Timon, Fabio Matrone, Giulia Marvaso, Luca Nicosia, Lucia Ognibene, Annamaria Vinciguerra, Luca Eolo Trodella, Ciro Franzese, Paolo Borghetti et al. · 2021 · Clinical & Translational Oncology
  22. Restaging of Patients with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy Using [68Ga]-PSMA-11 Positron Emission Tomography/Computed Tomography: Impact on Disease Management
    Mathieu Gauthé, Paul Sargos, Nicolas Benziane-Ouaritini, Éric Barret, Jean‐Baptiste Beauval, L. Brureau, G. Créhange, Charles Dariane, G. Fiard, Gaëlle Fromont et al. · 2022 · European Urology
  23. Prostate Cancer
    William G. Nelson, Emmanuel S. Antonarakis, H. Ballentine Carter, Angelo Michael De Marzo, Theodore L. DeWeese · 2020 · Elsevier eBooks
  24. Salvage Radiotherapy Plus Androgen Deprivation Therapy for High-Risk Prostate Cancer with Biochemical Failure after High-Intensity Focused Ultrasound as Primary Treatment
    Ying-Che Huang, Chih‐Hsiung Kang, Wei‐Chia Lee, Yuan‐Tso Cheng, Yao‐Chi Chuang, Hung‐Jen Wang, Fu‐Min Fang, Po‐Hui Chiang · 2022 · Journal of Clinical Medicine
  25. Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical Trial
    Loïc Ah-Thiane, L. Campion, Nedjla Allouache, Emmanuel Meyer, Pascal Pommier, Nathalie Mesgouez‐Nebout, Anne-Agathe Serre, G. Créhange, Valentine Guimas, Emmanuel Rio et al. · 2024 · European Urology Oncology
  26. Androgen deprivation therapy combined with postoperative radiotherapy for prostate cancer management
    Alan S Pollack, Alan Dal Pra · 2024 · The Lancet
  27. Post-prostatectomy radiation therapy: Updated guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group (FROGG)
    Matthew Warrender‐Sparkes, Jonathan Mark Tomaszewski, Christopher Chi Kit Ip, Sarat Chander, David Christie, Niall M. Corcoran, Louise Emmett, Renee Finnigan, Amy J. Hayden, Braden Higgs et al. · 2024 · Radiotherapy and Oncology
  28. ALDH1A3 Regulates Cellular Senescence and Senescence-Associated Secretome in Prostate Cancer
    Sen Wang, Lin Wang, Yu Zhao · 2025 · Cancers
  29. Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy
    David Dewei Yang, Vinayak Muralidhar, Brandon Arvin Virgil Mahal, Michelle Daniel Nezolosky, Shelby A. Labe, Marie E. Vastola, Ninjin Boldbaatar, Martin T. King, Neil E. Martin, Peter F. Orio et al. · 2017 · Urologic Oncology Seminars and Original Investigations
  30. Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience
    Danielle Lee Rodin, Michael R. Drumm, Rebecca Helen Clayman, Daniela L. Buscariollo, Sigolene Galland-Girodet, Alec Eidelman, Adam Scott Feldman, Douglas M. Dahl, Francis J. McGovern, Aria F. Olumi et al. · 2017 · Clinical Genitourinary Cancer
  31. Comparative quality-adjusted survival analysis between radiation therapy alone and radiation with androgen deprivation therapy in patients with locally advanced prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 85-31 with novel decision analysis methods
    Soyeon Ahn, Minjung Lee, Chang Wook Jeong · 2018 · Prostate International
  32. Clinical Outcomes of Postoperative Radiotherapy Following Radical Prostatectomy in Patients with Localized Prostate Cancer: A Multicenter Retrospective Study (KROG 18-01) of a Korean Population
    Sung Uk Lee, Kwan Ho Cho, Won Park, Won Kyung Cho, Kim Js, Chan Woo Wee, Young Seok Kim, Jin Ho Kim, Taek‐Keun Nam, Jaeho Cho et al. · 2019 · Cancer Research and Treatment
  33. Radiation treatment in prostate cancer: covering the waterfront
    Sophia C. Kamran, Anthony Laurence Zietman · 2021 · British Journal of Urology
  34. Managing postoperative biochemical relapse in prostate cancer, from the perspective of the Francophone group of Urological radiotherapy (GFRU)
    Loïc Ah-Thiane, Paul Sargos, O. Chapet, Marjory Jolicoeur, Mario Terlizzi, Carl Salembier, Jihane Boustani, Célia Prevost, Sonya Gaudioz, Talar Derashodian et al. · 2023 · Cancer Treatment Reviews
  35. Prostate cancer and elective nodal radiation therapy for cN0 and pN0—a never ending story?
    Stefan Alexander Koerber, Stefan Höcht, Daniel M. Aebersold, Clemens F. Albrecht, Dirk Boehmer, Ute Ganswindt, Nina-Sophie Schmidt-Hegemann, Tobias Hölscher, Arndt-Christian Mueller, Peter Niehoff et al. · 2024 · Strahlentherapie und Onkologie
  36. Systemic Treatment for Biochemical Recurrence of Localized Prostate Cancer: Do Not EMBARK on When, If the Answer Is How
    Bertrand F. TOMBAL, Gianluca Giannarini · 2024 · Journal of Clinical Oncology
  37. Radiation Oncology in the 21st Century: Prospective Randomized Trials That Changed Practice… or Didn’t!
    Kaveh Zakeri, C. Norman Coleman, Bhadrasain Vikram · 2018 · Frontiers in Oncology
  38. Early salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: Its impact and optimal candidate
    Natsuo Tomita, Kaoru Uchiyama, Tomoki Mizuno, Mikiko Imai, Chikao SUGIE, Shiho Ayakawa, Masanari Niwa, Tooru Matsui, S. Otsuka, Yoshihiko Manabe et al. · 2020 · Asia-Pacific Journal of Clinical Oncology
  39. Long- versus short-term androgen deprivation therapy with high-dose radiotherapy for biochemical failure after radical prostatectomy: a randomized controlled trial
    Charlien Berghen, Steven Joniau, Annouschka Laenen, Gaëtan Devos, Kato Rans, Karolien E. Goffin, Karin M. Haustermans, Gert De Meerleer · 2020 · Future Oncology
  40. Comparative Analysis of 5-Year Clinical Outcomes and Patterns of Failure of Proton Beam Therapy Versus Intensity Modulated Radiation therapy for Prostate Cancer in the Postoperative Setting
    Andrew R. Barsky, Ruben Carmona, Vivek Verma, Patricia Mae G. Santos, Stefan Both, Justin E. Bekelman, John Paul Christodouleas, Neha Vapiwala, Curtiland Deville · 2020 · Practical Radiation Oncology
  41. Prostatectomy with or without post-operative radiotherapy: long-term adverse effects and quality of life
    Kari V. Monsen, Sophie D. Fosså, Alv Andreas Dahl, Tor Åge Myklebust, Sigbjørn Smeland, Andreas Stensvold · 2020 · Scandinavian Journal of Urology
  42. Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy
    Sung Uk Lee, Kwan Ho Cho, Jin Ho Kim, Young Seok Kim, Taek‐Keun Nam, Kim Js, Jaeho Cho, Seo Hee Choi, Su Jung Shim, Jin Hee Kim et al. · 2021 · Technology in Cancer Research & Treatment
  43. Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer
    Pedro C. Lara, J.I. Rodríguez-Melcón, Amalia Palacios, Antonio José Lozano, Asuncion Hervas, Elena Villafranca, Alfonso Gomez Iturriaga, Gemma Sancho, Xavier Maldonado · 2022 · Frontiers in Oncology
  44. Radiation therapy after radical surgery in prostate cancer
    Roberto Paz-Manrique, Gerard Morton, Fernando Quiroa Vera, Santiago Paz-Manrique, Andrés Espinoza-Briones, Carlos Manuel Morante Deza · 2023 · ecancermedicalscience
  45. Node Oligorecurrence in Prostate Cancer: A Challenge
    Almudena Zapatero, Antonio Jose Conde-Moreno, Marta Barrado Los Arcos, Diego Aldave · 2023 · Cancers
  46. Clinical Efficacy and Openness to New Challenges of Low Dose Rate Brachytherapy for Prostate Cancer
    Manabu Kato, Shinichiro Higashi, Yusuke Sugino, Shinya Kajiwara, Shiori Tanaka, Goshi Kitano, Yasuhumi Yamashita, Yuji Ogura, Hiroyuki Tachibana, Takahiro Kojima et al. · 2023 · Current Oncology
  47. Initial clinical outcomes for prostate cancer patients undergoing adjuvant or salvage proton therapy after radical prostatectomy
    Curtiland Deville, Wei‐Ting Hwang, Andrew R. Barsky, Stefan Both, John Paul Christodouleas, Justin E. Bekelman, Zelig A Tochner, Neha Vapiwala · 2020 · Acta Oncologica
  48. Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy
    Gunnar Lohm, Konrad Neumann, Volker Budach, Thomas Wiegel, Stefan Hoecht, Johannes Gollrad · 2017 · Strahlentherapie und Onkologie
  49. Salvage radiation therapy after radical prostatectomy: survival analysis
    Andrea Galla, Angelo Maggio, Elena Delmastro, Elisabetta Garibaldi, Pietro Gabriele, Sara Bresciani, Amalia Di Dia, Michele Stasi, Domenico Gabriele · 2019 · Minerva Urologica e Nefrologica
  50. Predictive value of Prostate Specific Antigen variations in the last week of salvage radiotherapy for biochemical recurrence of prostate cancer after surgery: A practical approach
    Riccardo Vigna‐Taglianti, Alberto Boriano, Luca Gianello, Antonella Melano, Fabrizio Bergesio, Anna Maria Merlotti, Alessia Reali, Rachele Petrucci, Elvio Grazioso Russi · 2020 · Cancer Reports
  51. Differential Expression of a Panel of Ten CNTN1-Associated Genes during Prostate Cancer Progression and the Predictive Properties of the Panel towards Prostate Cancer Relapse
    Yan Jennifer Gu, Mathilda Jing Chow, Anil Kapoor, Xiaozeng Lin, Wenjuan Mei, Damu Tang · 2021 · Genes
  52. Surrogate end points in early prostate cancer clinical states: ready for implementation?
    Christos E. Kyriakopoulos, Emmanuel S. Antonarakis · 2017 · Annals of Translational Medicine
  53. French AFU Cancer Committee Guidelines – Update 2024–2026: Prostate cancer – Management of metastatic disease and castration resistance
    Guillaume Ploussard, Charles Dariane, Romain Mathiéu, Michaël Baboudjian, Éric Barret, L. Brureau, G. Fiard, Gaëlle Fromont, Jonathan Olivier, François Rozet et al. · 2024 · The French Journal of Urology
  54. Personalized intensification of treatment for hormone-sensitive prostate cancer
    Michael A. Cilento, Lisa M. Butler, Louise Emmett, Christopher J. Sweeney · 2025 · Nature Reviews Clinical Oncology
  55. Characterization of metabolism-associated molecular patterns in prostate cancer
    Bowei Yang, Yongming Jiang, Jun Yang, Wenbo Zhou, Tongxin Yang, Rongchang Zhang, Jinming Xu, Haixiang Guo · 2023 · BMC Urology
  56. Natural history of an immediately detectable PSA following radical prostatectomy in a contemporary cohort
    Peter Eoin Lonergan, Janet E. Cowan, Samuel L. Washington, Scott A. Greenberg, Hao Gia Nguyen, Peter R. Carroll · 2021 · The Prostate
  57. Histology Specific Molecular Biomarkers: Ushering in a New Era of Precision Radiation Oncology
    Philip Anthony Sutera, Heath Devin Skinner, Matthew E. Witek, Mark Vikas Mishra, Young Kwok, Elai Davicioni, Felix Yi-Chung Feng, Daniel Y. Song, Elizabeth M. Nichols, Phuoc Tho Tran et al. · 2023 · Seminars in Radiation Oncology
  58. Systematic review and integrated analysis of prognostic gene signatures for prostate cancer patients
    Yang An, Wenyuan Lu, Shijia Li, Xiaoyan Lu, Yuanyuan Zhang, Dongcheng Han, Dingyuan Su, Jiaxin Jia, Jiaxin Yuan, Binbin Zhao et al. · 2023 · Discover Oncology
  59. Prostate Cancer: Improving the Flow of Research
    C.A. Lawton · 2018 · Radiology
  60. Early Versus Delayed Initiation of Salvage Androgen Deprivation Therapy and Risk of Prostate Cancer–Specific Mortality
    Brandon Arvin Virgil Mahal, Ming‐Hui Chen, Andrew A. Renshaw, Marian J. Loffredo, Philip W. Kantoff, Anthony Victor D'Amico · 2018 · Journal of the National Comprehensive Cancer Network
  61. Quality of Life and Decision Regret After Postoperative Radiation Therapy to the Prostatic Bed Region With or Without Elective Pelvic Nodal Radiation Therapy
    Carola Link, Patrick R Honeck, Frank Lohr, Christian Bolenz, Joerg Schaefer, Markus Bohrer, Frank Anton Giordano, Frederik K. Wenz, Daniel Buergy · 2019 · Practical Radiation Oncology
  62. Comparison Between Dose-Escalated Intensity Modulated Radiation Therapy and 3-Dimensional Conformal Radiation Therapy for Salvage Radiation Therapy After Prostatectomy
    Nana Shimoyachi, Yasuo Yoshioka, Kazuma Sasamura, Junji Yonese, Shinya Yamamoto, Takeshi Yuasa, Takashi Soyano, Takuyo Kozuka, Masahiko Oguchi · 2021 · Advances in Radiation Oncology
  63. Subpathologies and genomic classifier for treatment individualization of post-prostatectomy radiotherapy
    Matthew Ramotar, Melvin L.K. Chua, Hong Truong, Ali Hosni, Melania Pintilie, Elai Davicioni, Neil Eric Fleshner, Adam Paul Dicker, Robert Glen Bristow, Hansen H. He et al. · 2021 · Urologic Oncology Seminars and Original Investigations
  64. The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy
    Line V. Hjelle, Marie Grøn Sælen, Erling Aarsæther, Tore Knutsen, Sigve Andersen, Anne Gry Bentzen, Elin H. Richardsen, Tom Wilsgaard, Sophie D. Fosså, Hege Sagstuen Haugnes · 2023 · European Urology Open Science
  65. ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy
    Piet R. Dirix, Alan Dal Pra, Vincent S Khoo, C. Carrié, C. Cozzarini, Valérie Fonteyne, Pirus Ghadjar, Alfonso Gomez Iturriaga, Nina-Sophie Schmidt-Hegemann, Valeria Panebianco et al. · 2023 · Clinical and Translational Radiation Oncology
  66. Role of Ga68 Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Prostate Cancer Imaging
    Jaykanth Amalachandran, Thangalakshmi Sivathapandi, Gopinathraj Gunasekaran · 2024 · Journal of Gastrointestinal and Abdominal Radiology
  67. Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics?
    Gustavo Arruda Viani, Ana Carolina Hamamura, Alexandre Ciuffi Correa, Felipe Teles de Arruda · 2019 · International braz j urol
  68. Drug Intensification in Future Postoperative Radiotherapy Practice in Biochemically-Relapsing Prostate Cancer Patients
    Axel Cailleteau, Paul Sargos, Fred Saad C, I. Latorzeff, Stéphane Supiot · 2021 · Frontiers in Oncology
  69. Multiparametric MRI for prostate cancer: a national survey of patterns of practice among radiation oncologists in Spain
    The Urological Tumours Working Group of the Spanish Society of Radiation Oncology (URONCOR/SEOR), Felipe Couñago, Gemma Sancho, Alfonso Gomez Iturriaga, Ivan Henriquez · 2018 · Clinical & Translational Oncology
  70. Multiparametric magnetic resonance imaging-guided salvage radiotherapy in prostate cancer
    Felipe Couñago, Ana Aurora Díaz-Gavela, Gemma Sancho, Irene Ortiz, Francisco José Marcos, Manuel Recio Rodríguez, Julio Fernández, Raquel Laveda Cano, Mar Jiménez de la Peña, Israel J. Thuissard et al. · 2019 · Reports of Practical Oncology & Radiotherapy
  71. Influence of Concomitant Androgen Deprivation Therapy and Its Duration for Salvage Radiation After Radical Prostatectomy: A Systematic Review and Network Meta-analysis According to Published Data
    Quynh Chi Le, Carolin Siech, Benedikt Hoeh, Fred Saad C, Felix Preißer, Derya Tilki, Markus Graefen, Tobias Maurer, MAXIMILIAN CHRISTIAN KRIEGMAIR, Pierre I. Karakiewicz et al. · 2025 · European Urology Oncology
  72. Androgen receptor splice variant expression and prostate cancer recurrence after salvage therapy
    David Joseph Konieczkowski, Keisuke Otani, Zoe Guan, Michael R. Drumm, Yukako S. Otani, Priscilla Oluwakemi Badusi, Ella H. Chung, Shulin Wu, Elai Davicioni, Philip James Saylor et al. · 2025 · npj Precision Oncology
  73. Cancer treatment–related cognitive impairment
    Bryan J. Neth, Sanne B. Schagen, J. S. Wefel · 2026 · Neuro-Oncology Advances
  74. The impact of positive surgical margins on salvage radiation or androgen deprivation therapy following radical prostatectomy – a nationwide study
    Hein Vincent Stroomberg, Anne Sofie Friberg, John Thomas Helgstrand, Klaus Brasso, Martin Andreas Røder · 2021 · Acta Oncologica
  75. Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial
    Samuel Tremblay, Mofarej Alhogbani, Andrew James Weickhardt, Ian D. Davis, Andrew Mark Scott, Rodney J. Hicks, Ur Metser, Sue Chua, Reena Davda, Shonit Punwani et al. · 2023 · Cancer Imaging
  76. Stereotactic Body Radiation Therapy Salvage for Lymph Node Recurrent Prostate Cancer in the Era of PSMA PET Imaging
    Omar E. Hayek, Soroush Rais‐Bahrami, Andrew Michael McDonald, Samuel Joseph Galgano · 2023 · Current Urology Reports
  77. Dose-Intensified Postoperative Radiation Therapy for Prostate Cancer: Long-Term Results From the PKUFH Randomized Phase 3 Trial
    Hongzhen Li, Xin Qi, Xianshu Gao, Xiaomei Li, Shangbin Qin, Xiao-ying Li, Ming-wei Ma, Yun Bai, Jiayan Chen, Xueying Ren et al. · 2023 · International Journal of Radiation Oncology*Biology*Physics
  78. Impact of radiation doses on clinical relapse of biochemically recurrent prostate cancer after prostatectomy
    Seiya Takano, Natsuo Tomita, Masanari Niwa, Akira Torii, Taiki Takaoka, Nozomi Kita, Kaoru Uchiyama, Mikiko Nakanishi-Imai, Shiho Ayakawa, Masato Iida et al. · 2024 · Scientific Reports
  79. Salvage Androgen Deprivation Therapy as Potential Treatment for Recurrence after Robot-Assisted Radical Prostatectomy
    Hiroshi Kano, Yoshifumi Kadono, Renato Naito, Tomoyuki Makino, Hiroaki Iwamoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Kouji Izumi et al. · 2024 · Cancers
  80. Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives
    Fabio Turco, Consuelo Buttigliero, Marco Donatello Delcuratolo, Silke Gillessen, Ursula Maria Vogl, Thomas Zilli, Nicola Fossati, Andrea Gallina A, Giovanni Farinea, Rosario Francesco Di Stefano et al. · 2024 · Clinical Genitourinary Cancer
  81. Treatment‐related changes in the prostate: past, present and future therapies
    Katrina Collins, Liang Cheng C · 2025 · Histopathology
  82. “Das PSMA-PET/CT soll bei allen Patienten mit biochemischem Progress nach radikaler Prostatektomie für eine frühe Tumordetektion eingesetzt werden.”
    Dirk Böhmer, Thorsten Schlomm, Thomas Maurer, Ambros Johannes Beer, Heinz Schmidberger, Jörg Kotzerke · 2018 · Nuklearmedizin - NuclearMedicine
  83. National trends in the management of patients with positive surgical margins at radical prostatectomy
    Kamyar Ghabili, Henry Soo-Min Park, James B. Yu, Preston C. Sprenkle, Simon P. Kim, Kevin A. Nguyen, Xiaomei Ma, Cary Philip Gross, Michael Leapman · 2020 · World Journal of Urology
  84. 68Ga-PSMA-PET screening and transponder-guided salvage radiotherapy to the prostate bed alone for biochemical recurrence following prostatectomy: interim outcomes of a phase II trial
    Patrick Bowden, Andrew W. See, Kevin So, Nathan Lawrentschuk, DANIEL A. MOON, Declan G. Murphy, Ranjit Rao, Alan Crosthwaite, Dennis King, Hodo Z. Haxhimolla et al. · 2021 · World Journal of Urology
  85. Clinical Effects of Jiawei Danggui Beimu Kushen Pills in the Treatment of Prostate Cancer and Their Influence on the Expression of Serum Prostate Specific Antigen
    Haiyang Zhao, Zhiqiang Ren, Guangwen Wang · 2021 · Evidence-based Complementary and Alternative Medicine
  86. Efficacy and safety of salvage radiotherapy combined with endocrine therapy in patients with biochemical recurrence after radical prostatectomy: A systematic review and meta-analysis of randomized controlled trials
    Zhanpeng Liang, Sihong Lin, Huiqin Lai, Luzhen Li, Jiaming Wu, Huatang Zhang, Cantu Fang · 2023 · Frontiers in Oncology
  87. Salvage Whole-Pelvic Radiation and Long-Term Androgen-Deprivation Therapy in the Management of High-Risk Prostate Cancer: Long-Term Update of the McGill 0913 Study
    Sara H. Elakshar, Marwan Tolba, Steven Tisseverasinghe, Laurie Pruneau, Vanessa Di Lalla, Boris Bahoric, Tamim Mohammad Niazi · 2023 · Current Oncology
  88. Overview of Radiation Therapy in the Management of Localized and Metastatic Prostate Cancer
    Malcolm David Mattes · 2024 · Current Urology Reports
  89. The expanding role of radiation oncology across the prostate cancer continuum
    Sasha Swensen, Jay Justin Liao, Jonathan J. Chen, Katherine K. Kim, Ting Martin Ma, Emily Steinberger Weg · 2024 · Abdominal Radiology
  90. Current status and perspectives on the use of androgen receptor pathway inhibitors in the salvage radiotherapy setting
    Vérane Achard, Thomas Zilli · 2024 · Prostate Cancer and Prostatic Diseases
  91. Oncological control in high-risk prostate cancer after radical prostatectomy and salvage radiotherapy compared to radiotherapy plus primary hormone therapy
    Jorge Caño-Velasco, Felipe Herranz-Amo, G. Barbas Bernardos, Lucía Polanco-Pujol, F. Verdú-Tartajo, Enrique Lledó-García, Carlos Hernández Fernández · 2019 · Actas Urológicas Españolas (English Edition)
  92. Use of combined androgen deprivation therapy with postoperative radiation treatment for prostate cancer: Impact of randomized trials on clinical practice
    Noelia Sanmamed, Rachel Glicksman, Jaime Omar Herrera-Caceres, Eric J. Lehrer, Jaqueline Heaton, Aaron Richard Hansen, Peter W M Chung, Neil Eric Fleshner, Robert Benjamin Den, Nicholas George Zaorsky et al. · 2020 · Urologic Oncology Seminars and Original Investigations
  93. Single‐fraction image‐guided robotic radiosurgery efficiently controls local prostate cancer recurrence after radical prostatectomy
    Annabel Spek, Anno Graser, Gregor Habl, Alexander Muacevic, Christoph Fürweger, M. Seitz, Alfred Haidenberger · 2020 · BJUI Compass
  94. Androgen Flare after LHRH Initiation Is the Side Effect That Makes Most of the Beneficial Effect When It Coincides with Radiation Therapy for Prostate Cancer
    Nicola Joseph Nasser · 2022 · Cancers
  95. Management of Biochemical Recurrence of Prostate Cancer After Curative Treatment: A Focus on Older Patients
    Lancelot Tremeau, Nicolas Mottet · 2022 · Drugs & Aging
  96. Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study
    Myong Kim, Cheryn Song, In Gab Jeong, Seung-Kwon Choi, Myungchan Park, Myungsun Shim, Young Seok Kim, Dalsan You, Jun Hyuk Hong, Choung‐Soo Kim et al. · 2018 · BMC Cancer
  97. Null association between androgen-deprivation therapy and nonprostate cancer mortality among older men with nonmetastatic prostate cancer
    Christopher J. D. Wallis, Raj Satkunasivam, Sender Herschorn, Calvin Law, Arun K. Seth, Ronald T. Kodama, Girish S. Kulkarni, Robert K. Nam · 2018 · Urologic Oncology Seminars and Original Investigations
  98. Overview of Systemic Therapy Augmenting Management of High-risk Localized Prostate Cancer
    Cécile Vicier, Felix Yi-Chung Feng, Karim S. Fizazi · 2019 · European Urology Focus
  99. Postoperative elective pelvic nodal irradiation compared to prostate bed irradiation in locally advanced prostate cancer – a retrospective analysis of dose-escalated patients
    Carola Link, Patrick R Honeck, Akiko Makabe, Frank Anton Giordano, Christian Bolenz, Joerg Schaefer, Markus Bohrer, Frank Lohr, Frederik K. Wenz, Daniel Buergy · 2019 · Radiation Oncology
  100. High-risk, recurrent and oligometastatic prostate cancer: recent developments on the role of radiation
    Jason K. Molitoris, Gregory S. Alexander, O.M. Siddiqui, Justin Cohen, Mark Vikas Mishra, Zaker Hamid Rana · 2021 · Current Opinion in Oncology